Trade Names:
Synonyms:
Status: Approved (2014)
Entry Type: Small molecule
Molecule Category: Parent
UNII: D26OSN9Q4R

Structure

InChI Key FYMHQCNFKNMJAV-HOTGVXAUSA-N
Smile N#Cc1c(N2C[C@@H]3NCCO[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12
InChI
InChI=1S/C20H19FN4O4/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28)/t15-,16-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C20H19FN4O4
Molecular Weight 398.39
AlogP 1.22
Hydrogen Bond Acceptor 7.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 3.0
Polar Surface Area 107.59
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 29.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR DNA gyrase inhibitor FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Otitis Externa 3 D010032 ClinicalTrials
Urinary Tract Infections 2 D014552 ClinicalTrials
Otitis Media 2 D010033 ClinicalTrials
Pyelonephritis 2 D011704 ClinicalTrials

Related Entries

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 209342-40-5
ChEBI 85176
ChEMBL CHEMBL1908370
DrugBank DB09047
DrugCentral 4920
EPA CompTox DTXSID10175096
FDA SRS D26OSN9Q4R
Guide to Pharmacology 10809
PubChem 11567473
SureChEMBL SCHEMBL1002869
ZINC ZINC000003985346